Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Learn more What our patients are saying Real experiences from verified RenuviaRX patients
Its clinical development for obesity was discontinued in 2007 after the pivotal 536-participant Phase IIb trial failed to meet its primary efficacy endpoint, and no formulation of the compound has received FDA approval since
Some people need six weeks
"Cancel anytime": Brand-stated
Subcutaneous Injection Mechanism: Direct injection into the subcutaneous fat layer, bypassing barriers like the digestive or nasal mucosa
The compounded versions also did not use the same auto-injectors as the branded versions
US$ 23.49
US$ 22.68
US$ 28.01
US$ 22.01
